How Much Is the Inevitable Loss of Different Coagulation Factors During Blood Product–Free Liver Transplantations?

Bloodless liver transplantations (LT) have already been reported, but special characteristics of hemostatic changes remain less defined. The aim of this study was to evaluate the “inevitable” loss of coagulation factors (CF) in blood product–free LT. Blood product and CF concentrate–free LT patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2020-12, Vol.52 (10), p.2988-2995
Hauptverfasser: Rengeiné, T.K., Máthé, Z., Piros, L., Dinya, E., Smudla, A., Mándli, T., Kóbori, L., Doros, A., Kanizsai, P., Fazakas, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Bloodless liver transplantations (LT) have already been reported, but special characteristics of hemostatic changes remain less defined. The aim of this study was to evaluate the “inevitable” loss of coagulation factors (CF) in blood product–free LT. Blood product and CF concentrate–free LT patient data were analyzed in terms of the first 2 days of perioperative hemostasis kinetics (N = 59). CF levels (FI, II, V, VII, X, and XIII), platelet (PLT) levels, and hemoglobin levels were measured before LT (T1), on arrival at the intensive care unit (T2), and 12, 24, and 48 hours after LT (T3, T4, and T5, respectively). Thromboelastographic (TEG) parameters were determined before and at the end of LT (T1-T2). Fibrinogen levels decreased by 1.2 ± 0.6 g/L, prothrombin levels by 26% ± 14%, factor V levels by 40% ± 23%, VII levels by 29% ± 19%, and X levels by 39% ± 22% (P 
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2020.05.006